

Cover Story
The Centers for Medicare and Medicaid Services appear to be executing a two-step strategy to shrink the $8 billion annual price tag of clinical diagnostic laboratory tests.
By Matthew Bin Han Ong
In Brief


Funding Opportunities
Drugs & Targets


Trending Stories
- Harvey Risch, critic of COVID-19 response, tapped by White House to serve as chair of the President’s Cancer Panel
- Brown University reaches agreement with Trump administration to restore funding
- House passes Mikaela Naylon Give Kids a Chance Act—next step, the Senate
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- John Byrd brings blood cancer expertise to solid tumor, immunology powerhouse at UPMC
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program











